1. Home
  2. MGLD vs MDCX Comparison

MGLD vs MDCX Comparison

Compare MGLD & MDCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MGLD
  • MDCX
  • Stock Information
  • Founded
  • MGLD 1996
  • MDCX 2008
  • Country
  • MGLD United States
  • MDCX United States
  • Employees
  • MGLD N/A
  • MDCX N/A
  • Industry
  • MGLD Finance/Investors Services
  • MDCX
  • Sector
  • MGLD Finance
  • MDCX
  • Exchange
  • MGLD Nasdaq
  • MDCX Nasdaq
  • Market Cap
  • MGLD 44.8M
  • MDCX 50.8M
  • IPO Year
  • MGLD N/A
  • MDCX N/A
  • Fundamental
  • Price
  • MGLD $1.01
  • MDCX $2.36
  • Analyst Decision
  • MGLD
  • MDCX Strong Buy
  • Analyst Count
  • MGLD 0
  • MDCX 2
  • Target Price
  • MGLD N/A
  • MDCX $23.50
  • AVG Volume (30 Days)
  • MGLD 4.7K
  • MDCX 378.0K
  • Earning Date
  • MGLD 11-07-2025
  • MDCX 11-22-2025
  • Dividend Yield
  • MGLD N/A
  • MDCX N/A
  • EPS Growth
  • MGLD N/A
  • MDCX N/A
  • EPS
  • MGLD N/A
  • MDCX N/A
  • Revenue
  • MGLD $30,154,000.00
  • MDCX N/A
  • Revenue This Year
  • MGLD N/A
  • MDCX N/A
  • Revenue Next Year
  • MGLD N/A
  • MDCX N/A
  • P/E Ratio
  • MGLD N/A
  • MDCX N/A
  • Revenue Growth
  • MGLD N/A
  • MDCX N/A
  • 52 Week Low
  • MGLD $0.64
  • MDCX $1.79
  • 52 Week High
  • MGLD $2.10
  • MDCX $8.94
  • Technical
  • Relative Strength Index (RSI)
  • MGLD 46.70
  • MDCX 49.17
  • Support Level
  • MGLD $1.03
  • MDCX $2.33
  • Resistance Level
  • MGLD $1.08
  • MDCX $2.48
  • Average True Range (ATR)
  • MGLD 0.05
  • MDCX 0.19
  • MACD
  • MGLD -0.01
  • MDCX -0.02
  • Stochastic Oscillator
  • MGLD 12.21
  • MDCX 38.46

About MGLD The Marygold Companies Inc.

The Marygold Companies Inc is a holding company that intends to focus on financial services. It is currently directing its investments towards financial services and the emerging Fintech space.

About MDCX Medicus Pharma Ltd. Common Stock

Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.

Share on Social Networks: